Completed NA INTERVENTIONAL 2-arm NCT04065061

Erinacine A-enriched Hericium Erinaceus Mycelia for Improvement of Recognition, Vision, and Functional MRI Alterations

Investigation of Erinacine A-enriched Hericium Erinaceus Mycelia for Improvement of Recognition, Vision, and Functional MRI Alterations

Sponsor: Chung Shan Medical University

Conditions Cognition Disorders in Old Age Supplement Vision fMRI

Interventions Erinacine A-enriched Hericium Erinaceus Mycelia Placebo

Updated 4 times since 2019 Last updated: Aug 20, 2019 Started: May 22, 2015 Primary completion: May 10, 2016 Completion: May 10, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Cognition Disorders in Old Age and Supplement, this trial is completed. The trial is conducted by Chung Shan Medical University and has accumulated 4 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Sep 2019 — Jan 2021 [monthly]

Completed NA

First recorded

May 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chung Shan Medical University
Grape King Bio Ltd.

Data source: Chung Shan Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taichung, Taiwan